Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Rafael Díaz,M.D., director of Estudios Clínicos Latinoamérica in Rosario, Argentina

News | Coronavirus (COVID-19)

Prescription Omega-3 Pill Did Not Affect Outcome for Non-hospitalized Adults With COVID-19

November 19, 2021 — A high dose of a purified omega-3 fatty acid, available by prescription only, was well tolerated ...

November 19, 2021

Oral PCSK9 Inhibitor Lowering Cholesterol in First Human Trial

News | Pharmaceuticals

Oral PCSK9 Inhibitor Safe and Effective in Lowering Cholesterol in First Human Trial

November 19, 2021 — Results from two early clinical studies show the first version of an oral PCSK9-inhibitor ...

November 19, 2021

Coronary Artery Bypass Grafting (CABG). #AHA21

News | Cardiovascular Surgery

Moderna Announces Positive Data from Phase 2 Study of mRNA VEGF-A in Patients Undergoing CABG

November 18, 2021 — Moderna Inc. announced positive data from the AstraZeneca-led Phase 2 (EPICCURE) study evaluating ...

November 18, 2021

Repair of Tricuspid Valve Leak CTCR-MVS - Evaluating the Benefit of Concomitant Tricuspid Repair During Mitral Valve Surgery.

News | Structural Heart

Repair of Tricuspid Valve Leak During Mitral Valve Surgery May Benefit Some Adults

November 18, 2021 — Adults undergoing mitral valve surgery who have less than severe leakage of the tricuspid valve may ...

November 18, 2021

Cardiovascular Surgery Ticagrelor - significant increase in bleeding when people had bypass surgery after two to three days of discontinuing ticagrelor. #AHA #AHA21

News | Cardiovascular Surgery

Time From Stopping Blood Thinner To Bypass Surgery May Be Shortened for Select Patients

November 18, 2021 — People who are on the antiplatelet medication ticagrelor and need coronary artery bypass surgery may ...

November 18, 2021

About 57% of the people with high blood pressure achieved normal blood pressure levels after 18 months of the village doctor-led intervention program.Blood Pressure Hypertension. #AHA21

News | Hypertension

Village Doctor-led Intervention Effective in BP Control, Adds Health Care Access Options

November 18, 2021 — Village doctors who were community health workers in rural China were trained and successfully ...

November 18, 2021

News | Wearables

Novel Algorithm on Wearable Devices Can Detect Irregular Heartbeat, May Prompt Early Care

November 18, 2021 — A novel software algorithm compatible with a wide range of smartwatches and fitness trackers ...

November 18, 2021

Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline among adults with type 2 diabetes, according to the late-breaking ASCEND study presented at the American Heart Association’s Scientific Sessions 2021. Type 2 Diabetes and Aspirin Regimen. #AHA

News | Antiplatelet and Anticoagulation Therapies

Long-term, Low-dose Aspirin Did Not Affect Risk of Dementia in Adults With Type 2 Diabetes

November 17, 2021 — Taking daily low-dose aspirin for seven years did not affect the risk of dementia or mental decline ...

November 17, 2021

News | Atrial Fibrillation

Monitoring for Individual Triggers May Reduce Episodes of Atrial Fibrillation

November 17, 2021 — People with atrial fibrillation (AFib) who underwent individualized testing to discover triggers for ...

November 17, 2021

Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and quality of life within 3 months for people with heart failure due to either reduced or preserved cardiac function, even if they didn’t also have type 2 diabetes, according to the late-breaking CHIEF-HF study presented at the American Heart Association’s Scientific Sessions 2021. Type 2 Diabetes Canagliflozin 100mg Tablet.

News | Heart Failure

Heart Failure Symptoms Improved With a Type 2 Diabetes Medicine in Fully Remote Trial

November 17, 2021 — Canagliflozin, a medication used to treat type 2 diabetes, was found to greatly improve symptoms and ...

November 17, 2021

News | EP Lab

Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy for Atrial Fibrillation

November 16, 2021 — Acutus Medical Inc. (Acutus), an arrhythmia management company focused on improving the way cardiac ...

November 16, 2021

News | Pharmaceuticals

Bempedoic Acid Alone Lowered LDL-C Levels Comparable to Moderate or High-intensity Statin

November 15, 2021 — Esperion announced the presentation of three abstracts highlighting Nexletol tablets at the American ...

November 15, 2021

News | Pharmaceuticals

Inclisiran Reduced LDL-C in Obese Patients

November 15, 2021 — Novartis announced results from a pooled post-hoc analysis of Phase III ORION-9, -10 and -11 trials ...

November 15, 2021

Penumbra Indigo System CAT RX Thrombectomy system was involved in the CHEETAH Trial, study at TCT 2021.#TNT

News | Thrombectomy Devices

New Data Demonstrate Safety and Performance of Continuous Aspiration Thrombectomy With Penumbra’s Indigo System CAT RX Catheter

November 12, 2021 — Penumbra Inc. announced that the CHEETAH clinical study of its Indigo System CAT RX Catheter ...

November 12, 2021

News | Hypertension

Pacemaker for Hypertension Shows Significant Clinical Impact

November 12, 2021 — Orchestra BioMed Inc. announced multiple presentations of long-term clinical results and ISH ...

November 12, 2021